Folpe et al developed a classification scheme for the histologic diagnosis of atypical and malignant glomus tumors. The authors are from Emory University in Atlanta.
Glomus cells show immunohistochemical features of modified smooth muscle cells.
Parameters:
(1) location (superficial to muscular fascia or deep to it, page 2 column 1)
(2) size
(3) mitotic rate per high power field (400x total magnification, microscopic field area not stated)
(4) mitotic figures
(5) nuclear atypia/grade (low, moderate or high)
(6) growth pattern
Classification:
(1) malignant glomus tumor ("glomangiosarcoma")
(2) symplastic glomus tumor (glomus tumor with nuclear atypia)
(3) glomus tumor of uncertain malignant potential
(4) glomangiomatosis
(5) benign glomus tumor
Malignant glomus tumor - one or more of the following criteria:
(1) large size (>= 2 cm) AND deep location
(2) atypical mitotic figures
(3) high nuclear grade (marked nuclear atypia) AND high mitotic activity (>= 5 per 50 high power fields)
Symplastic glomus tumor - all of the following:
(1) high nuclear grade (marked atypia)
(2) mitotic rate < 5 per 50 high power fields
(3) does not meet other criteria for malignancy
Glomus tumor of uncertain malignant potential - one or more of the following:
(1) superficial location AND high mitotic activity (>= 5 per 50 high power fields)
(2) large size (>= 2 cm) only
(3) deep location only
Glomangiomatosis - both of the following:
(1) does not meet criteria for malignant glomus tumor, symplastic glomus tumor, or glomus tumor of uncertain malignant potential
(2) diffuse growth with excess glomus cells, resembling angiomatosis
Benign glomus tumor: none of the above
Specialty: Hematology Oncology, Surgery, general